Keyphrases
Methylation
100%
Axin2
100%
Recurrence Prediction
100%
Dickkopf-1 (DKK1)
100%
Stage II Colon Cancer
100%
Robust Biomarker
100%
Confidence Interval
44%
Consensus Molecular Subtypes
44%
Area under the Curve
33%
Colon Cancer Patients
33%
Adjuvant Therapy
22%
Microsatellite Stable
22%
Gene Methylation
22%
Tumor
11%
Validation Cohort
11%
Hazard Ratio
11%
Prognostic Biomarker
11%
Clinical Parameters
11%
Multivariate Analysis
11%
Colon Cancer
11%
DNA Methylation (DNAm)
11%
MRNA Expression
11%
Patient Stratification
11%
Lgr5
11%
Prognostic Marker
11%
Worse Prognosis
11%
Academic Medical Centers
11%
Quantitative Methylation-specific PCR (Q-MSP)
11%
Poor Prognosis Patients
11%
Recurrence-free Survival
11%
Ascl2
11%
Pyrosequencing
11%
BRAF mutant
11%
CpG Island Methylator Phenotype
11%
Marker Combination
11%
APCDD1
11%
Biochemistry, Genetics and Molecular Biology
Methylation
100%
Colon
100%
AXIN2
100%
DKK1
100%
Microsatellite
16%
DNA Methylation
8%
LGR5
8%
CpG Island
8%
Recurrence Free Survival
8%
Multivariate Analysis
8%
Pyrosequencing
8%
Messenger RNA
8%
Immunology and Microbiology
Colon
100%
Methylation
100%
Recurrence Free Survival
8%
Prognostic Biomarker
8%
CpG Island
8%
DNA Methylation
8%
Pyrosequencing
8%